MICHAEL ELLER: Open Payments
NPI 1952636201 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 71 payments from 22 companies in 2025. Trend: 2023 $1,151 · 2024 $1,152 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $334 |
| Novo Nordisk Inc | 8 | $153 |
| PFIZER INC. | 9 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Lilly USA, LLC | 3 | $54 |
| Amgen Inc. | 3 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
Products named: VRAYLAR, Wegovy, Kerendia, UBRELVY, ELIQUIS, Auvelity, Ozempic, MOUNJARO.
Industry payments across PA — which companies pay providers there.
